Article
Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.
Human molecular genetics - 1 Nov 2014
Neben Cynthia L, Idoni Brian, Salva Joanna E, Tuzon Creighton T, Rice Judd C, Krakow Deborah, Merrill Amy E
Abstract excerpt
Fibroblast growth factor receptor 2 (FGFR2) promotes osteoprogenitor proliferation and differentiation during bone development, yet how the receptor elicits these distinct cellular responses remains unclear. Analysis of the FGFR2-skeletal disorder bent bone dysplasia syndrome (BBDS) demonstrates that FGFR2, in addition to its canonical signaling activities at the plasma membrane, regulates bone formation from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
